Sim&Cure and Siemens Healthineers Join Forces to Revolutionize Brain Aneurysm Treatment

August 21, 2024 — Montpellier, France, and Erlangen, Germany — Sim&Cure, a leading innovator in imaging and numerical modeling for brain aneurysm treatments, and Siemens Healthineers, a global leader in medical technology, are excited to announce a strategic partnership aimed at enhancing patient care and advancing brain aneurysm treatment.

An estimated 1 in 50 people harbors a brain aneurysm, a hidden condition that can become life-threatening if it ruptures. Immediate medical intervention is crucial for ruptured aneurysms, while proactive management of unruptured aneurysms can prevent future health crises. Despite the lack of symptoms from most brain aneurysms, their detection and treatment remain critical to preventing potential ruptures and associated health issues.

This partnership brings together the expertise and techology leadership of both companies to create and promote innovative solutions designed to improve the precision and effectiveness of brain aneurysm interventions. By combining Sim&Cure’s cutting-edge simulation technology with Siemens Healthineers’ advanced imaging systems, the collaboration will offer healthcare professionals state-of-the-art tools to enhance diagnosis, treatment planning, and patient outcomes.

Driving Innovation Through Collaboration

This partnership aims to highlight the complementary nature of their products to improve patient care. By enabling Sim&Cure's simulation technologies with Siemens Healthineers' imaging capabilities, the collaboration will provide healthcare professionals with advanced tools to enhance diagnosis, treatment planning, and patient pathway. Through coordinated efforts, both companies will demonstrate the significant benefits of their solutions for brain aneurysm treatment.

Both companies are committed to maintaining the highest standards of quality and compliance. Their common activities will be led jointly, ensuring consistency and alignment with each company's brand and regulatory requirements. This collaborative approach will help to effectively communicate the advantages of the combined technologies to healthcare providers worldwide.

Enhancing Patient Care Today and Tomorrow

The partnership between Sim&Cure and Siemens Healthineers is driven by a shared vision to improve patient care by advancing the tools available for brain aneurysm treatment. By leveraging Sim&Cure’s numerical modeling technology with Siemens Healthineers’ image-guidance solutions, healthcare professionals will be better equipped to design personalized treatment plans that are both safer and more effective.

This collaboration not only represents a significant step forward in the current capabilities of brain aneurysm treatment but also sets the stage for future innovations. By leveraging the strengths of both companies, Sim&Cure and Siemens Healthineers are poised to deliver groundbreaking solutions that will shape the future of neurovascular care.

A Partnership with a Purpose

“We are thrilled to partner with Siemens Healthineers, a company that shares our dedication to improving patient outcomes through innovation,” said Mathieu Sanchez, CEO and Co-founder of Sim&Cure. “This collaboration allows us to combine our expertise in numerical modeling with Siemens Healthineers’ unparalleled imaging technology, creating a powerful synergy that will benefit both healthcare providers and patients.”

Dr. Jayant Saha, Head of Global Business Development - Interventional Radiology, Advanced Therapies, Siemens Healthineers, added, “Instilling greater clinical confidence by delivering high performance and value to our customers is at the core of everything we do. Simulation in neurovascular aneurysm treatment is proving to be an important and growing indispensable tool in interventional neuroradiology. Siemens Healthineers and Sim&Cure hereby look forward to offering cutting edge technological advances in the field of neurovascular aneurysm treatment to our joint customers and the patients they care for.”

About Sim&Cure

Sim&Cure is a French-based medical technology company that specializes in the development of simulation software for neurovascular procedures. Their flagship product, Sim&Size, is a CE-marked and FDA-cleared software that assists clinicians in the planning of endovascular treatments for brain aneurysms. The company is dedicated to improving patient outcomes by providing innovative, user-friendly tools that support precise treatment planning.

About Siemens Healthineers

Siemens Healthineers is a leading global medical technology company headquartered in Erlangen, Germany. With a focus on advancing healthcare through innovative technologies, Siemens Healthineers offers a comprehensive portfolio of imaging, laboratory diagnostics, and advanced therapy solutions. The company is committed to supporting healthcare providers worldwide in delivering high-quality care and improving patient outcomes.

Contact Information

For more information, please contact:

Sim&Cure

• Mathieu SanchezCEO and Co-founder,
• [email protected]

Siemens Healthineers

• Dr. Jayant SahaHead of Global BD-IR, Advanced Therapies,
• [email protected]